Mr Jack Wood

BCom

Non-Executive Director

Mr Wood has an extensive background in international marketing and manufacture of pharmaceutical products. He has lived in Germany, England, Australia, USA and Canada and overseen pharmaceutical operations throughout Europe, Asia and North America. He currently is Chairman of EnGene Corporation and a Director of QLT; both are companies engaged in biotechnology and headquartered in Vancouver Canada. He is an active member of several civic boards and organizations in Vancouver Canada where he now resides. Prior to joining the Pharmaceutical Industry, Mr Wood served in the Canadian Armed Forces retiring with the rank of Lt. Col.

Positions held by Mr Wood during his career include Executive Vice President CSL Limited Australia, where he coordinated the company’s worldwide expansion in the plasma products industry. President and CEO Exogene Corporation, Senior Vice President BioResponse Corporation - both biotechnology companies sold to Baxter Healthcare Corporation. Vice President Bayer Corporation Pharmaceutical division responsible for operations in Europe and Japan.

Mr Wood spent over seventeen years with Baxter Healthcare Corporation holding a series of operating and general management positions in North America, Europe, Asia and Australia.

Investors' Blog Posts

We've just released the first results from our vitiligo program which you can view online here. Following their release, we expect a number...

Read More

Clinuvel Non-Executive Director Brenda Shanahan has been honoured at The Australian Financial Review and Westpac Group Woman of Influence...

Read More

Since we publicly announced our vitiligo program in 2010, the entire Clinuvel team has aimed to gain a better understand this disease, its...

Read More

Related Webcasts

Taking on Vitiligo, a depigmentation disorder of the skin. In 2010, Clinuvel ventured into an area of dermatology where no other pharmaceut...

Watch now

Taking on Vitiligo, a depigmentation disorder of the skin. In 2010, Clinuvel ventured into an area of dermatology where no other pharmaceut...

Watch now

Taking on Vitiligo, a depigmentation disorder of the skin. In 2010, Clinuvel ventured into an area of dermatology where no other pharmaceut...

Watch now

Investor Spotlight